We’re closing out 2025 with an immunodermatology–focused issue of the Journal of Drugs in Dermatology. From incretin-based therapies for hidradenitis suppurativa (HS) to real-world data on cardiometabolic risk in inflammatory skin disease, these Editor’s Picks connect skin and systemic health with practical pearls for clinic. GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A …

Continue reading "JDD December 2025 Issue Highlights | Special Focus: Immunodermatology"